Transient effects of multi‐infusion ketamine augmentation on treatment‐resistant depressive symptoms in patients with treatment‐resistant bipolar depression – An open‐label three‐week pilot study

Abstract Introduction While the psychiatric benefits of ketamine have been verified through clinical trials, there is limited information about ketamine augmentation in patients with treatment‐resistant bipolar depression (TRBPD). Hence, in the present study, we investigate the therapeutic efficacy...

Full description

Bibliographic Details
Main Authors: Chuanjun Zhuo, Feng Ji, Hongjun Tian, Lina Wang, Feng Jia, Deguo Jiang, Ce Chen, Chunhua Zhou, Xiaodong Lin, Jingjing Zhu
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Brain and Behavior
Subjects:
Online Access:https://doi.org/10.1002/brb3.1674